Centiva Capital LP trimmed its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 54.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,494 shares of the semiconductor company’s stock after selling 1,764 shares during the period. Centiva Capital LP’s holdings in Synopsys were worth $725,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in SNPS. Vanguard Group Inc. boosted its stake in Synopsys by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 14,482,776 shares of the semiconductor company’s stock valued at $7,029,360,000 after acquiring an additional 120,575 shares during the last quarter. Capital World Investors lifted its stake in Synopsys by 1.6% in the fourth quarter. Capital World Investors now owns 7,280,182 shares of the semiconductor company’s stock valued at $3,533,526,000 after purchasing an additional 114,893 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Synopsys by 21.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company’s stock valued at $2,864,933,000 after purchasing an additional 1,045,326 shares during the period. Geode Capital Management LLC increased its position in Synopsys by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 3,357,165 shares of the semiconductor company’s stock worth $1,625,230,000 after buying an additional 75,298 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of Synopsys by 26.2% in the fourth quarter. Ameriprise Financial Inc. now owns 1,888,181 shares of the semiconductor company’s stock valued at $916,441,000 after buying an additional 391,681 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Up 0.9 %
Shares of NASDAQ SNPS opened at $484.85 on Friday. The stock’s 50-day simple moving average is $436.44 and its two-hundred day simple moving average is $489.23. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $624.80. The firm has a market capitalization of $74.97 billion, a P/E ratio of 33.39, a P/E/G ratio of 3.23 and a beta of 1.16.
Analyst Ratings Changes
Check Out Our Latest Stock Report on Synopsys
Insider Transactions at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the transaction, the chief executive officer now owns 70,922 shares of the company’s stock, valued at $32,890,077.50. The trade was a 13.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Geus Aart De sold 15,705 shares of the firm’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the sale, the insider now owns 116,671 shares in the company, valued at approximately $51,850,925.82. This trade represents a 11.86 % decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- IBM’s AI Offensive: Assessing IBM’s Path to Renewed Growth
- How to Short a Stock in 5 Easy StepsĀ
- Rockwell Automation: Tailwinds From Onshoring U.S. Production
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Is Energy Transfer Undervalued or a Value Trap?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.